You are here:
Home
NICE Guidance
Conditions and diseases
Cystic fibrosis
OxyMask for delivering oxygen therapy
Medtech innovation briefing
Reference number:
MIB160
Published:
27 September 2018
Download (PDF)
Overview
Summary
The technology
Regulatory information
Equality considerations
Clinical and technical evidence
Specialist commentator comments
Specialist commentators
Development of this briefing
Regulatory information
OxyMask is a CE marked class IIa medical device.
Next page
Equality considerations
Previous page
The technology
Back to top